World-leading science journal Nature has published a paper from the Department of Obstetrics and Gynaecology at the University of Cambridge. Entitled “Human placenta has no microbiome but can contain potential pathogens”, the paper Read more
Cambridge University Hospitals NHS Foundation Trust (CUH) has been revealed as England’s top performing trust for increasing research in the annual National Institute for Health Research Read more
Study shows that in HER2 positive early breast cancer 6 months treatment with Herceptin is as good as 12 months for preventing cancer return
NIHR Cambridge BRC and CRUK breast cancer study could help patients and save millions of pounds worldwide.Read more
A Cambridge-based study has shown that the diagnosis and treatment of some of the most critically ill babies can be improved by sequencing their whole genome.Read more
Virtual reality (VR) can identify early Alzheimer’s disease more accurately than ‘gold standard’ cognitive tests currently in use, suggests new research.Read more
A study led by researchers at the University of Cambridge and published this week in PLOS Medicine has found that offering universal late pregnancy ultrasounds at 36 weeks’ gestation eliminates Read more
Discovery of genetic variants that protect against obesity and type 2 diabetes could lead to new weight loss medicines
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research from the University of Cambridge.Read more
The nation’s world-leading researchers in nutrition and physical activity have pledged to work together to tackle challenges associated with obesity and sedentary behaviours. Read more
A device developed by a Cambridge researcher to make prostate biopsies safer has begun clinical trials.
University of Cambridge and Cambridge University Hospitals (CUH) researcher and urologist, Mr Vincent Gnanapragasam (right), first developed Read more
The research team behind a clinical trial to investigate a preventative therapy for rheumatoid arthritis are greatly encouraged after exceeding their patient recruitment target.
The study, supported by the NIHR Joint Translational Research Read more